Role of the Neutrophil-Lymphocyte Ratio in the Differential Diagnosis of Exudative Pleural Effusion by Akturk, Ulku Aka et al.
Role of the Neutrophil-Lymphocyte Ratio in the
Differential Diagnosis of Exudative Pleural Effusion
Ulku Aka Akturk,* Dilek Ernam, Makbule Ozlem Akbay, Nagihan Durmus Koc¸ak, Erhan Ogur, Ilim Irmak
Sureyyapas¸a Chest Disease and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey
OBJECTIVES: Pleural effusion is a common diagnostic and clinical problem. The differential diagnosis of pleural
effusion may be difficult and may require several procedures, including invasive ones. Certain studies have
investigated biochemical parameters to facilitate the diagnosis of exudative pleural effusion; however, it
remains a challenging problem in clinical practice. We aimed to investigate the potential role of the neutrophil-
lymphocyte ratio, which can be easily obtained by determining the cell count of the pleural fluid, in the
differential diagnosis of exudative pleural effusion.
METHODS: Records from patients who underwent thoracentesis and pleural fluid analysis between May 1, 2013,
and March 1, 2015, were obtained from the electronic database of our hospital. The patients who met the
inclusion criteria were divided into five groups according to their diagnosis: malignant pleural effusion, para-
malignant pleural effusion, para-pneumonic effusion, tuberculosis-related effusion or other. The neutrophil-
lymphocyte ratio value was calculated by dividing the absolute neutrophil count by the absolute lymphocyte
count. The patient groups were compared according to the given parameter.
RESULTS: A total of 465 patients who met the inclusion criteria among 1616 patients with exudative pleural
effusion were included in the study. The mean neutrophil-lymphocyte ratio value was significantly lower in
tuberculosis-related pleural effusion compared to malignant, para-pneumonic and para-malignant effusions
(p=0.001, p=0.001, p=0.012, respectively). The areas under the curve for tuberculosis pleurisy compared to
malignant, para-pneumonic and para-malignant effusions were 0.38, 0.36, and 0.37, respectively. Lower cut-off
values had higher sensitivity but lower specificity for tuberculosis pleurisy, while higher cut-off values had
higher specificity but lower sensitivity for this condition.
CONCLUSION: The pleural fluid neutrophil-lymphocyte ratio, which is an inexpensive, reproducible, and easily
calculated hematological parameter, may facilitate the differential diagnosis of pleural effusion.
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’ INTRODUCTION
Pleural effusion is a common clinical problem, and its
differential diagnosis may sometimes be difficult and may
require several procedures, including invasive ones. The
most common causes of exudative pleural effusion include
cancer and tuberculosis (TB). Although many biochemical
parameters, such as lactate dehydrogenase (LDH), C-reactive
protein (CRP), adenosine deaminase (ADA), interferon
gamma and procalcitonin levels, have been studied in the
context of the diagnosis of exudative pleural effusion (1-5),
its diagnosis is still challenging.
During the last few years, the neutrophil-lymphocyte ratio
(NLR) has been investigated as a new inflammatory marker.
Although the relationship between the NLR and lung cancer
has been most frequently investigated among studies on
lung diseases (6,7), a few studies have investigated use of the
NLR values in the pleural fluid for the differential diagnosis
of bacterial pneumonia and TB pleural effusion (8,9).
In the present study, we aimed to investigate the potential
role of the NLR, which can be easily obtained by determining
the cell count of the pleural fluid, in the differential diagnosis
of exudative pleural effusion.
’ MATERIALS AND METHODS
Study population
This study was designed as a retrospective cohort study
and conducted as a single-center study at a tertiary care
hospital with a high patient bed capacity.
The records of patients who underwent thoracentesis and
pleural fluid analysis betweenMay 1, 2013, andMarch 1, 2015,DOI: 10.6061/clinics/2016(10)10
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were obtained from the electronic database of our hospital.
Patients with transudative pleural effusion according to
the Light criteria (10), with empyema and/or hemothorax,
whose pleural fluid cell count was not analyzed or who did
not have a final diagnosis were excluded from the study
(Figure 1).
The study protocol was approved by the local ethics
committee of the hospital in accordance with the Declaration
of Helsinki. Due to the retrospective nature of the study
design, informed consent was not required.
Data
The demographic characteristics, the final diagnoses based
on clinical evaluation and invasive procedures, and the
pleural fluid parameters of the patients were recorded
(Figure 1). The patients were divided into five groups
according to their final diagnosis: malignant pleural effusion,
para-malignant pleural effusion, para-pneumonic effusion,
TB pleurisy or other (e.g., chronic renal failure or rheumatic
disease). In certain patients with chronic renal failure,
exudative pleural effusion developed because of previously
established pleural effusion. All disease groups were com-
pared according to their NLR values.
Definitions
The NLR value was calculated by dividing the absolute
neutrophil count by the absolute lymphocyte count. These
counts were obtained from a pleural fluid analysis.
Malignant pleural effusion was diagnosed when the
pleural fluid cytology and/or pleural biopsy findings were
positive for malignancy.
Para-malignant effusion was defined as effusion secondary
to lung cancer without evidence of pleural invasion.
TB pleurisy was diagnosed according to positive myco-
bacterium TB culture findings for the pleural fluid and/or
the presence of caseous granulomas in a pleural biopsy
specimen after exclusion of other granulomatous disease.
Para-pneumonic effusion was diagnosed according to the
presence of cough, fever and a radiographic pulmonary
infiltrate that disappeared with antibiotics.
Renal failure was identified according to increased urea
and creatinine levels and clinical evidence of both fluid
overload and an absence of purulent sputum, malignancy
and pulmonary infiltrates.
Statistical analyses
The definitive statistical data are expressed as frequencies,
percentages, means, standard deviations, medians, and/or
Figure 1 - Flow chart.
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quartiles. The chi-square test was used to compare catego-
rical variables. The Mann-Whitney U test was used to com-
pare continuous variables between two groups. A p-value
of o0.05 was considered significant. Receiver operating
characteristic (ROC) curves were also used to evaluate the
diagnostic value of NLR values for predicting the diagnosis
of malignant effusion, TB pleurisy, para-pneumonic effusion
and para-malignant pleural effusion.
The statistical analyses were performed using the SPSS
program (SPSS version 16; SPSS Inc., Chicago, IL, USA).
’ RESULTS
Records from 2486 patients who underwent thoracentesis
and pleural fluid analysis between May 1, 2013, and March 1,
2015, were collected from the automated database system of
our hospital. A total of 465 patients who met the inclusion
criteria among 1616 patients with exudative pleural effusion
were included in the study (Figure 1). The mean age of the
patients was 64±18 years (62.3% male; 37.5% female).
According to pleural fluid analyses, pleural effusion resulted
from malignant diseases in 177 (38.1%) patients and from
benign diseases in 288 (61.9%) patients. The cause of the
presence of pleural fluid was malignant pleural effusion in
177 (38.1%) patients, TB pleurisy in 101 (21.5%) patients,
para-pneumonic pleural effusion in 91 (19.4%) patients, para-
malignant pleural effusion in 45 (9.8%) and other causes
(such as chronic renal failure or rheumatic disease) in 56
(11.2%) patients. The mean and median NLR values were
calculated for each disease group and were compared
between paired groups (Table 1).
The difference in median NLR values between malignant
(;3.5, 1.6-7.5) and benign (3.3, 1.2-7.0) pleural effusions was
not statistically significant (p=0.55). In contrast, the median
NLR value was significantly lower in TB pleurisy (2.2)
compared to malignant (3.5), para-pneumonic (4.1) and para-
malignant (4.2) pleural effusions (p=0.001, p=0.001, and
p=0.012, respectively). However, there was no difference
between malignant, para-pneumonic and para-malignant
effusions.
In view of the significantly higher values of the pleural
NLR in malignant, para-pneumonic and para-malignant
effusions compared to TB pleurisy, ROC analysis and
determination of the cut-off values, sensitivity and specifi-
city of this parameter for the differentiation of TB pleurisy
from these effusions were carried out using paired groups.
In particular, ROC curves were drawn for the NLRs of each
pair of diseases, and the values of the area under the curve
(AUC) were calculated (Figures 2 A, B, C , Table 2).
The AUC values for TB pleurisy compared to malignant,
para-pneumonic and para-malignant effusions were 0.38,
0.36, and 0.37, respectively. Lower cut-off values had higher
sensitivity but lower specificity for TB pleurisy, while higher
cut-off values had higher specificity but lower sensitivity
for this condition (Table 2); i.e., for malignant effusions, the
0.4 cut-off value had 90% sensitivity for TB pleurisy, the
8.8 cut-off value had 80% specificity for TB pleurisy, and
the 9.5 cut-off value had 85% specificity for TB pleurisy. Of
the 101 patients who were diagnosed with TB pleurisy, only
8 (8.8%) had an NLR value of 9.5 or higher. Additionally,
40% of patients with TB pleurisy had an NLR value between
0.4 and 1.4.
’ DISCUSSION
In this study, we investigated the cell counts of exudative
pleural effusions and these counts’ potential contribution to
differential diagnosis by calculating the NLR, which can
easily be calculated from the pleural fluid cell count and
which has been utilized as an inflammatory marker in recent
years. The pleural fluid NLR value was significantly lower in
TB-related effusion compared to the values in malignant,
para-malignant and para-pneumonic effusions. However,
this ratio’s potential role in differential diagnosis between
malignant, para-pneumonic and para-malignant effusions
seems to be limited because these conditions present nearly
the same NLR values. In any case, in the appropriate clinical
context, lower NLR values may be considered as favoring TB
pleurisy, while higher values may be used to rule out TB
pleurisy. Alternatively, NLR values at least may be used in
tailoring the choice of further diagnostic tests, whether
invasive or non-invasive.
Many biochemical parameters have been investigated
regarding the differential diagnosis of exudative pleural
effusion (1-5). Among these parameters, the most frequently
studied are the pleural fluid biochemical parameters ADA
Table 1 - Comparison of pleural fluid NLRs between the exudative pleural disease groups.
Diagnosis (n) Median (IQR) p-value
Malignant pleural effusion 3.5 (1.6-7.5) 0.001
TB pleurisy 2.2 (0.9-5.3)
Malignant pleural effusion 3.5 (1.6-7.5) 0.48
Para-pneumonic pleural effusion 4.1 (1.8-7.4)
Malignant pleural effusion 3.5 (1.6-7.5) 0.58
Para-malignant effusion 4.2 (1.0-11.8)
TB pleurisy 2.2 (0.9-5.3) 0.001
Para-pneumonic pleural effusion 4.1 (1.8-7.4)
TB pleurisy
Para-malignant effusion
2.2 (0.9-5.3)
4.2 (1.0-11.8)
0.012
Para-malignant effusion
Para-pneumonic pleural effusion
4.2 (1.0-11.8)
4.1 (1.8-7.4)
0.31
IQR: Interquartile range
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and CRP as well as parameters, such as the NLR, that easily
can be calculated by determining the cell count of the pleural
fluid (1,3,5,8,11).
Exudative pleural effusion is present in a variety of
pathological conditions in clinical practice and is mostly
associated with malignancy and TB (2). The incidence of
malignant pleural fluid correlates with age. The most
common extrapulmonary form of TB is pleural TB, which
specifically occurs in countries with endemic TB (12).
According to data from Turkey, the pleural TB rate among
extrapulmonary TB cases was 31.1% in 2011. While nearly
half of the cases were in individuals between 15 and 35 years
of age, 27% were in individuals older than 50 years (13). The
differential diagnosis of pleural effusion is difficult, and
many laboratory investigations, including invasive proce-
dures, are required. No standard pleural marker has been
identified for use in differential diagnosis before moving on
to more invasive procedures. For that reason, parameters,
such as the NLR, that can easily be calculated and that are
widely available have a potential role in the evaluation of
exudative pleural effusion.
In a study investigating the role of biochemical parameters
in the differential diagnosis of pleural effusion, elevated
pleural LDH and low pleural ADA levels were found to be
associated with bronchogenic carcinoma; high levels of
pleural ADA, with TB; and high levels of both markers,
with complicated para-pneumonic effusion or empyema (14).
Combined use of ADA and the lymphocyte-neutrophil ratio
(LNR) was found to be more useful than use of ADA alone,
especially in TB pleural effusion (8,9,15).
The ADA levels in TB pleural effusion are significantly
higher compared to those in para-pneumonic, malignant
pleural and transudative effusions. In TB pleural effusion,
when ADA (X50 IU/L) is combined with the LNR (X0.75),
the sensitivity and specificity increase (8,15). In a study by
Antin et al (9), an LNR value40.75 in the pleural fluid was a
significant indicator of TB pleurisy compared to other
exudative effusions, which had lymphocyte predominance.
Previous studies have shown that pleural CRP values are
higher in pleural fluid of bacterial origin than in fluid
accumulating due to other etiologic causes and significantly
Figure 2B - ROC curve for the NLR by TB pleurisy and para-
pneumonic pleural effusion.
Figure 2A - ROC curve for the NLR by TB pleurisy and malignant
pleural effusion.
Figure 2C - ROC curve for the NLR by TB pleurisy and para-
malignant pleural effusion.
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higher in exudative fluids compared to transudative fluids
(1). Moreover, elevated CRP values in pleural effusion had
high sensitivity and specificity for the differential diagnosis
of para-pneumonic effusion and other exudative effusions
(16). However, the serum NLR value has been shown to be
superior to CRP for the differentiation of pulmonary TB and
bacterial pneumonia (17). In fact, an NLR value o7 may
differentiate pulmonary TB from bacterial pneumonia with
a high sensitivity and specificity.
Strengths and limitations
We compared all possible different exudative pleural
effusions and also confirmed our final diagnoses by further
invasive diagnostic tests. However, the sample size was
relatively small. Moreover, given that calculation of NLR
values seemed to be more helpful in TB pleurisy compared to
malignant, para-pneumonic and para-malignant effusions,
the potential use of this formula may be limited to countries
with high TB incidence. Another limitation is that in this
retrospective study, a pleural fluid cell count was not
performed for many patients, so these patients were
excluded from the study because of missing data. An
additional limitation of our study was that we only used
NLR values; adding other parameters, such as ADA levels,
to the evaluation could be more helpful for differential
diagnosis.
In conclusion, calculation of the pleural NLR may have a
role in the differential diagnosis of TB pleurisy, but not
malignant, para-pneumonic or para-malignant effusions. In
the appropriate clinical context, lower NLR values may be as
favoring TB pleurisy, while higher values may be used to
rule out TB pleurisy. Alternatively, NLR values at least may
be used in tailoring the choice of further diagnostic tests,
whether invasive or non-invasive, especially in countries
with a moderate or high TB incidence.
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